Australia markets close in 4 hours 11 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.45+1.20 (+12.97%)
At close: 04:00PM EDT
10.75 +0.30 (+2.87%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 715.52M
Enterprise value 562.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.75
Enterprise value/revenue N/A
Enterprise value/EBITDA -11.73

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 3-41.78%
S&P500 52-week change 3-13.66%
52-week high 323.73
52-week low 37.13
50-day moving average 310.25
200-day moving average 311.31

Share statistics

Avg vol (3-month) 3804.79k
Avg vol (10-day) 3878.14k
Shares outstanding 577.94M
Implied shares outstanding 6N/A
Float 875.59M
% held by insiders 13.02%
% held by institutions 132.84%
Shares short (30 Aug 2022) 49.1M
Short ratio (30 Aug 2022) 412.2
Short % of float (30 Aug 2022) 412.01%
Short % of shares outstanding (30 Aug 2022) 411.68%
Shares short (prior month 28 July 2022) 48.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 306 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.09%
Return on equity (ttm)-29.50%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-45.41M
Diluted EPS (ttm)-0.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)153.2M
Total cash per share (mrq)1.97
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)16.89
Book value per share (mrq)1.93

Cash flow statement

Operating cash flow (ttm)-27.87M
Levered free cash flow (ttm)-10.38M